Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effect of Liraglutide in Patients With Type 2 Diabetes and Severe Renal Insufficiency

NCT01394341 is registered in ClinicalTrials.gov with Bo Feldt-Rasmussen as lead sponsor.

NCT NCT01394341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01394341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effect of Liraglutide in Patients With Type 2 Diabetes and Severe Renal Insufficiency
Lead sponsor
Bo Feldt-Rasmussen
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2011
Completion date
October 31, 2013
Enrollment
40 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease, type 2 diabetes mellitus